Skip to main content

AbilityPharma: Accelerating Solutions for Pancreatic Cancer

Project description

New drug for the treatment of pancreatic cancer

Call for proposal

H2020-EIC-SMEInst-2018-2020-3
See other projects for this call

Funding Scheme

SME-2b - SME Instrument (grant only and blended finance)

Coordinator

ABILITY PHARMACEUTICALS SL
Address
Edifici Eureka - Campus De La Uab
08193 Barcelona
Spain
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 2 325 865,38